(Total Views: 568)
Posted On: 04/17/2023 6:47:33 PM
Post# of 156257
I had to look at it again. Ya definitely pretty clear. They need to fix this if it’s wrong.
“CytoDyn has submitted the first two sections (non-clinical and CMC) of its Biological License Application (BLA) for that indication and our team is working diligently on the clinical section. “
“CytoDyn has submitted the first two sections (non-clinical and CMC) of its Biological License Application (BLA) for that indication and our team is working diligently on the clinical section. “
(1)
(0)
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
